Upadacitinib
Products in Health Canada’s databases that list Upadacitinib as a medicinal or active ingredient, under this spelling. The same substance can be listed under another name (a salt, a common name), which has its own page.
- Drug products
- 3
- 3 authorized now
- Natural health products
- 0
- 0 active licences
- Notices of Compliance
- 21
- Products in all
- 3
Drug products
Authorized products first.
| Name | DIN | Status | Holder | Status since |
|---|---|---|---|---|
| RINVOQ (15 MG) | 02495155 | Marketed | AbbVie Corporation | |
| RINVOQ (30 MG) | 02520893 | Marketed | AbbVie Corporation | |
| RINVOQ (45 MG) | 02539721 | Marketed | AbbVie Corporation |
Notices of Compliance
Approvals of drug submissions that list it, newest first.
- RINVOQJuly 14, 2026 · NOC 37914
- RINVOQDecember 2, 2025 · NOC 36478
- RINVOQSeptember 9, 2025 · NOC 35978
- RINVOQAugust 21, 2025 · NOC 35878
- RINVOQApril 30, 2025 · NOC 35278
- RINVOQMarch 24, 2025 · NOC 35058
- RINVOQFebruary 26, 2025 · NOC 34911
- RINVOQJuly 5, 2024 · NOC 33589
- RINVOQOctober 31, 2023 · NOC 31974
- RINVOQOctober 12, 2023 · NOC 31834
- RINVOQJuly 21, 2023 · NOC 31270
- RINVOQMay 2, 2023 · NOC 30610
- RINVOQDecember 29, 2022 · NOC 29788
- RINVOQAugust 2, 2022 · NOC 28692
- RINVOQJuly 27, 2022 · NOC 28665
- RINVOQJuly 14, 2022 · NOC 28582
- RINVOQJanuary 28, 2022 · NOC 27501
- RINVOQOctober 6, 2021 · NOC 26803
- RINVOQJuly 27, 2021 · NOC 26334
- RINVOQJune 3, 2021 · NOC 25984
- RINVOQDecember 23, 2019 · NOC 23046